Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

104.08 -1.88 (-1.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,400,450
Open 105.80
Bid (Size) 104.08 (4)
Ask (Size) 104.99 (4)
Prev. Close 105.96
Today's Range 103.92 - 106.69
52wk Range 62.07 - 106.69
Shares Outstanding 1,253,809,440
Dividend Yield 2.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bullish Setups
You know things are bad when I stoop to offering some bullish setups, but that’s just where we’re at right now. 
Via Talk Markets
Topics Stocks / Equities
Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday
Via Benzinga

Performance

YTD
+13.28%
+13.28%
1 Month
+13.56%
+13.56%
3 Month
+17.66%
+17.66%
6 Month
+39.80%
+39.80%
1 Year
+45.40%
+45.40%

More News

Read More
Moderna (MRNA) Q4 Earnings Report Preview: What To Look For
Via StockStory
Top S&P500 movers in Wednesday's session
Via Chartmill
Why Gilead Sciences Stock Is Jumping Today
Via The Motley Fool
Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention
Via Benzinga
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Why Gilead Sciences (GILD) Stock Is Trading Up Today
Via StockStory
These S&P500 stocks are moving in today's session
Via Chartmill
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Discover the top S&P500 movers in Wednesday's pre-market session.
Via Chartmill
Gilead Wins Price-Target Boosts After Solid Q4, Retail Brushes Off Medicare Reform Hit To HIV Drugs
Via Stocktwits
Markets Mixed On Powell Testimony, Q4 Earnings
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Gilead Sciences Shares Push Higher After Q4 Report: Here's Why
Via Benzinga
Gilead Sciences Beats Q4 EPS Forecast
Via The Motley Fool
Gilead Sciences (NASDAQ:GILD) Delivers Strong Q4 Numbers
Via StockStory
Gilead Outplays Veklury Downfall To Obliterate Forecasts. Will Shares Win Back Their Breakout?
Via Investor's Business Daily
Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results
From Gilead Sciences, Inc.
Via Business Wire
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Via Benzinga
US Stock To Likely Open Lower Amid Tariff Tensions: Expert Hints Sans Lower Tariffs It's Hard To See The 'Market Going Up'
Via Benzinga
Earnings Scheduled For February 11, 2025
Via Benzinga
Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.